GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Statistics

Total Valuation

KRX:011000 has a market cap or net worth of KRW 208.38 billion. The enterprise value is 231.54 billion.

Market Cap	208.38B
Enterprise Value	231.54B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:011000 has 84.71 million shares outstanding. The number of shares has decreased by -53.51% in one year.

Current Share Class	84.71M
Shares Outstanding	84.71M
Shares Change (YoY)	-53.51%
Shares Change (QoQ)	+2.58%
Owned by Insiders (%)	10.01%
Owned by Institutions (%)	4.28%
Float	71.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.00
PB Ratio	3.33
P/TBV Ratio	3.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.59
EV / Sales	6.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.09

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.41.

Current Ratio	0.57
Quick Ratio	0.18
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-1.46
Interest Coverage	-14.41

Financial Efficiency

Return on equity (ROE) is -60.14% and return on invested capital (ROIC) is -23.23%.

Return on Equity (ROE)	-60.14%
Return on Assets (ROA)	-17.81%
Return on Invested Capital (ROIC)	-23.23%
Return on Capital Employed (ROCE)	-47.42%
Revenue Per Employee	846.70M
Profits Per Employee	-1.23B
Employee Count	41
Asset Turnover	0.25
Inventory Turnover	2.91

Taxes

Income Tax	-275.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.99% in the last 52 weeks. The beta is 0.57, so KRX:011000's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-1.99%
50-Day Moving Average	2,357.10
200-Day Moving Average	2,307.30
Relative Strength Index (RSI)	61.70
Average Volume (20 Days)	715,464

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:011000 had revenue of KRW 34.71 billion and -50.50 billion in losses. Loss per share was -1,000.26.

Revenue	34.71B
Gross Profit	-11.71B
Operating Income	-39.50B
Pretax Income	-50.77B
Net Income	-50.50B
EBITDA	-21.40B
EBIT	-39.50B
Loss Per Share	-1,000.26

Balance Sheet

The company has 2.72 billion in cash and 25.89 billion in debt, giving a net cash position of -23.16 billion or -273.45 per share.

Cash & Cash Equivalents	2.72B
Total Debt	25.89B
Net Cash	-23.16B
Net Cash Per Share	-273.45
Equity (Book Value)	62.49B
Book Value Per Share	737.75
Working Capital	-18.48B

Cash Flow

In the last 12 months, operating cash flow was -15.08 billion and capital expenditures -2.60 billion, giving a free cash flow of -17.69 billion.

Operating Cash Flow	-15.08B
Capital Expenditures	-2.60B
Free Cash Flow	-17.69B
FCF Per Share	-208.81

Margins

Gross margin is -33.74%, with operating and profit margins of -113.78% and -145.46%.

Gross Margin	-33.74%
Operating Margin	-113.78%
Pretax Margin	-146.25%
Profit Margin	-145.46%
EBITDA Margin	-61.64%
EBIT Margin	-113.78%
FCF Margin	n/a

Dividends & Yields

KRX:011000 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	53.51%
Shareholder Yield	n/a
Earnings Yield	-24.23%
FCF Yield	-8.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 3, 2021
Split Type	Forward
Split Ratio	1.5

Scores

KRX:011000 has an Altman Z-Score of -2.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.31
Piotroski F-Score	2